Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Torti

Showing results (51-60 of 263) with videos related to

Pageof 27
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|February 7, 2026
Management of infections caused by Gram-negative bacteria in severely immunocompromised hosts employing Outpatient Parenteral Antimicrobial Therapy (OPAT): Preliminary evidence from a real-world observational studyRosa Anna Passerotto, Gabriele Giuliano, Domenico Tarantino, et al.
World Journal of Gastroenterology|April 18, 2022
Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practiceNadia Marascio, Salvatore Rotundo, Angela Quirino, et al.
Clinical & Developmental Immunology|April 5, 2012
Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillanceManuela Fogli, Carlo Torti, Fabio Malacarne, et al.
Diagnostic Microbiology and Infectious Disease|February 14, 2026
Ecthyma gangrenosum in a young neutropenic patient with recent Dengue virus infectionFrancesca Catania, Federica Salvati, Flavio Sangiorgi, et al.
Antiviral Therapy|June 25, 2008
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIVEugenia Quiros-Roldan, Alessandra Calabresi, Giuseppe Lapadula, et al.
Open Forum Infectious Diseases|August 13, 2025
The Use of Oritavancin as Consolidation Therapy for Infective Endocarditis Caused by <i>Enterococcus</i> sppFederico Frondizi, Gabriele Maria Leanza, Marta Chiuchiarelli, et al.
BMC Infectious Diseases|October 22, 2025
HIV and tuberculosis co-infection in non-European migrants in Europe: a systematic review and meta-analysisDomenico Benvenuto, Elena Raffetti, Giancarlo Ceccarelli, et al.
Journal of Translational Medicine|February 18, 2021
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facilityFlavia Biamonte, Cirino Botta, Maria Mazzitelli, et al.
World Journal of Emergency Surgery : WJES|July 4, 2020
Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitisAndrea Bruni, Eugenio Garofalo, Valeria Zuccalà, et al.
Antiviral Therapy|February 17, 2007
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimensFranco Maggiolo, Diego Ripamonti, Carlo Torti, et al.
Pageof 27

Showing results (51-60 of 263) with videos related to

Sort By:
Pageof 27
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|February 7, 2026
Management of infections caused by Gram-negative bacteria in severely immunocompromised hosts employing Outpatient Parenteral Antimicrobial Therapy (OPAT): Preliminary evidence from a real-world observational studyRosa Anna Passerotto, Gabriele Giuliano, Domenico Tarantino, et al.
World Journal of Gastroenterology|April 18, 2022
Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practiceNadia Marascio, Salvatore Rotundo, Angela Quirino, et al.
Clinical & Developmental Immunology|April 5, 2012
Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillanceManuela Fogli, Carlo Torti, Fabio Malacarne, et al.
Diagnostic Microbiology and Infectious Disease|February 14, 2026
Ecthyma gangrenosum in a young neutropenic patient with recent Dengue virus infectionFrancesca Catania, Federica Salvati, Flavio Sangiorgi, et al.
Antiviral Therapy|June 25, 2008
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIVEugenia Quiros-Roldan, Alessandra Calabresi, Giuseppe Lapadula, et al.
Open Forum Infectious Diseases|August 13, 2025
The Use of Oritavancin as Consolidation Therapy for Infective Endocarditis Caused by <i>Enterococcus</i> sppFederico Frondizi, Gabriele Maria Leanza, Marta Chiuchiarelli, et al.
BMC Infectious Diseases|October 22, 2025
HIV and tuberculosis co-infection in non-European migrants in Europe: a systematic review and meta-analysisDomenico Benvenuto, Elena Raffetti, Giancarlo Ceccarelli, et al.
Journal of Translational Medicine|February 18, 2021
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facilityFlavia Biamonte, Cirino Botta, Maria Mazzitelli, et al.
World Journal of Emergency Surgery : WJES|July 4, 2020
Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitisAndrea Bruni, Eugenio Garofalo, Valeria Zuccalà, et al.
Antiviral Therapy|February 17, 2007
The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimensFranco Maggiolo, Diego Ripamonti, Carlo Torti, et al.
Pageof 27